| 000 | 01656 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516020858.0 | ||
| 264 | 0 | _c20110601 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1938-5404 | ||
| 024 | 7 |
_a10.1667/RR2317.1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNiermann, Kenneth J | |
| 245 | 0 | 0 |
_aEnhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated Aurora kinase B inhibition. _h[electronic resource] |
| 260 |
_bRadiation research _cApr 2011 |
||
| 300 |
_a444-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aAndrogens _xtherapeutic use |
| 650 | 0 | 4 | _aAurora Kinase B |
| 650 | 0 | 4 | _aAurora Kinases |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOrganophosphates _xadministration & dosage |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aQuinazolines _xadministration & dosage |
| 650 | 0 | 4 |
_aRadiation Tolerance _xdrug effects |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMoretti, Luigi | |
| 700 | 1 | _aGiacalone, Nicholas J | |
| 700 | 1 | _aSun, Yunguang | |
| 700 | 1 | _aSchleicher, Stephen M | |
| 700 | 1 | _aKopsombut, Prapaporn | |
| 700 | 1 | _aMitchell, Lauren R | |
| 700 | 1 | _aKim, Kwang Woon | |
| 700 | 1 | _aLu, Bo | |
| 773 | 0 |
_tRadiation research _gvol. 175 _gno. 4 _gp. 444-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1667/RR2317.1 _zAvailable from publisher's website |
| 999 |
_c20506739 _d20506739 |
||